Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button


Home > Press > Scientists Provide Technical Due Diligence To Investor Funds

Scientists Provide Technical Due Diligence To Investor Funds

August 30, 2005

A new venture, Bio Life Technical, including leading researchers within Nanotechnology and Personalized Healthcare, such as Professor Chris Toumazou and Professor Sir Magdi Yacoub of Imperial College, London, is being launched in London, UK, providing independent due diligence services to investors, globally. Bio Life Technical is structured to aid venture capital groups, investment banks, business angels and institutional investors by providing a single contact point and managing the technical due diligence reporting process on behalf of prospective investor clients. This will save time, resources and, therefore, money for the investment community. Professor Chris Toumazou said, “Medical Device technology is truly interdisciplinary. Bio Life Technical’s strategy of providing technical due diligence by expert professors from core disciplines and world class experts working with interdisciplinary institutes, such as Imperial College’s Institute of Biomedical Engineering, will enable a more thorough scientific evaluation of the technology.”

In addition, Bio Life Technical can estimate a quantitative commercial value for a device, even though it is at a pre-development stage without the usual financial inputs to rely on. Aiden Williamson, a partner in Bio Life Technical said “The Bio Life Technical service is a welcome development in the field of technical due diligence that will give investors a clear edge when it comes to the evaluation of investment opportunities.”

By specializing in Nanotechnology and Personalized Healthcare, Bio Life Technical is concentrating upon areas of high contemporary and future importance to the investment and financial community, industry, plus scientific and healthcare organisations. Each of the technologies could cause revolutionary and, in some cases, disruptive change in the status quo and growth prospects of most technology dependent business sectors. For this reason, Bio Life Technical retains a cross-disciplinary approach, ensuring a truly comprehensive reporting structure. The value-added element of the Bio Life Technical offering is technical analysis that cannot normally be undertaken by venture capital firms, early stage investors.

Paul Constant
Bio Life Technical LLP
10 John Street
United Kingdom
T: + 44 (0) 20 7067 4320
F: + 44 (0) 20 7067 4301
M: + 44 78 55 31 33 89

Copyright © Bio Life Technical LLP

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press


Nanometrics Announces Upcoming Investor Events November 18th, 2015

Harris & Harris Group Portfolio Company, D-Wave Systems, Announces Multi-Year Agreement With Lockheed Martin November 16th, 2015

Arrowhead Late-Breaking Clinical Data Shows that ARC-520 Can Produce Deep and Durable Reductions of Hepatitis B Viral Antigens and DNA November 16th, 2015

Harris & Harris Group Portfolio Company, D-Wave Systems, Announces the Sale of Its Latest Quantum Computer to Los Alamos National Laboratory November 11th, 2015


Stanford technology makes metal wires on solar cells nearly invisible to light November 27th, 2015

Dimensionality transition in a newly created material November 27th, 2015

Nanoparticles simplify DNA identification and quantification November 27th, 2015

A new form of real gold, almost as light as air November 27th, 2015

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project

Car Brands
Buy website traffic